RecruitingObesityOverweight and/or ObesityOverweight
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Eligible age
18+ yrs
Accepts
All genders
Locations
11 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to learn about the safety and effectiveness of berobenatide in adults with overweight or obesity who have already lost weight while taking semaglutide or tirzepatide. The study does not include people with diabetes. Participants will be in the study for about 11 months.
Sponsor: Pfizer
You may qualify if…
- ✓ Aged ≥18 years.
- ✓ Currently taking semaglutide or tirzepatide for obesity management.
You may not qualify if…
- ✕ Diagnosis of any form of diabetes.
- ✕ History of acute or chronic pancreatitis.
- ✕ Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN-2).
Where it's recruiting
Alabama
Birmingham
California
Los Angeles · Santa Ana · Walnut Creek
Florida
Jacksonville · New Port Richey · Oviedo
Kentucky
Louisville
Michigan
Flint
Mississippi
Ridgeland
Missouri
Chesterfield
Montana
Butte
North Carolina
Monroe · Wilmington
Ohio
Cincinnati
South Carolina
Greenville
Source: ClinicalTrials.gov · NCT07845500 · last updated 2026-10-15